0
     

Report Added
Report already added
Global Functional Dyspepsia Drug Market Growth 2021-2026

Global Functional Dyspepsia Drug Market Growth 2021-2026

According to this latest study, the 2021 growth of Functional Dyspepsia Drug will have significant change from previous year. By the most conservative estimates of global Functional Dyspepsia Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 5657.7 million in 2020. Over the next five years the Functional Dyspepsia Drug market will register a 2.9% CAGR in terms of revenue, the global market size will reach US$ 6344.3 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Functional Dyspepsia Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Prokinetic Drugs
Gastric Antisecretory Drugs
Others
The classification of Functional Dyspepsia Drug includes Prokinetic Drugs, Gastric Antisecretory Drugs, etc. The proportion of Gastric Antisecretory Drugs in 2019 is about 47.86%.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals
Drugstores
The application of Functional Dyspepsia Drug includes hospitals and drugstores. The proportion of hospitals in 2019 is about 63.85%.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Bayer
Sumitomo
Cadila Pharmaceuticals
Teva
Johnson & Johnson
Pfizer
Sanofi
AstraZeneca
Jiangsu Aosaikang Pharma
Eisai
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Functional Dyspepsia Drug Consumption 2016-2026
2.1.2 Functional Dyspepsia Drug Consumption CAGR by Region
2.2 Functional Dyspepsia Drug Segment by Type
2.2.1 Prokinetic Drugs
2.2.2 Gastric Antisecretory Drugs
2.2.3 Others
2.3 Functional Dyspepsia Drug Sales by Type
2.3.1 Global Functional Dyspepsia Drug Sales Market Share by Type (2016-2021)
2.3.2 Global Functional Dyspepsia Drug Revenue and Market Share by Type (2016-2021)
2.3.3 Global Functional Dyspepsia Drug Sale Price by Type (2016-2021)
2.4 Functional Dyspepsia Drug Segment by Application
2.4.1 Hospitals
2.4.2 Drugstores
2.5 Functional Dyspepsia Drug Sales by Application
2.5.1 Global Functional Dyspepsia Drug Sale Market Share by Application (2016-2021)
2.5.2 Global Functional Dyspepsia Drug Revenue and Market Share by Application (2016-2021)
2.5.3 Global Functional Dyspepsia Drug Sale Price by Application (2016-2021)

3 Global Functional Dyspepsia Drug by Company
3.1 Global Functional Dyspepsia Drug Sales Market Share by Company
3.1.1 Global Functional Dyspepsia Drug Sales by Company (2019-2021)
3.1.2 Global Functional Dyspepsia Drug Sales Market Share by Company (2019-2021)
3.2 Global Functional Dyspepsia Drug Revenue Market Share by Company
3.2.1 Global Functional Dyspepsia Drug Revenue by Company (2019-2021)
3.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Company (2019-2021)
3.3 Global Functional Dyspepsia Drug Sale Price by Company
3.4 Global Manufacturers Functional Dyspepsia Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Functional Dyspepsia Drug Product Location Distribution
3.4.2 Players Functional Dyspepsia Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Functional Dyspepsia Drug by Region
4.1 Global Functional Dyspepsia Drug by Region
4.1.1 Global Functional Dyspepsia Drug Sales by Region
4.1.2 Global Functional Dyspepsia Drug Revenue by Region
4.2 Americas Functional Dyspepsia Drug Sales Growth
4.3 APAC Functional Dyspepsia Drug Sales Growth
4.4 Europe Functional Dyspepsia Drug Sales Growth
4.5 Middle East & Africa Functional Dyspepsia Drug Sales Growth

5 Americas
5.1 Americas Functional Dyspepsia Drug Sales by Country
5.1.1 Americas Functional Dyspepsia Drug Sales by Country (2016-2021)
5.1.2 Americas Functional Dyspepsia Drug Revenue by Country (2016-2021)
5.2 Americas Functional Dyspepsia Drug Sales by Type
5.3 Americas Functional Dyspepsia Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Functional Dyspepsia Drug Sales by Region
6.1.1 APAC Functional Dyspepsia Drug Sales by Region (2016-2021)
6.1.2 APAC Functional Dyspepsia Drug Revenue by Region (2016-2021)
6.2 APAC Functional Dyspepsia Drug Sales by Type
6.3 APAC Functional Dyspepsia Drug Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Functional Dyspepsia Drug by Country
7.1.1 Europe Functional Dyspepsia Drug Sales by Country (2016-2021)
7.1.2 Europe Functional Dyspepsia Drug Revenue by Country (2016-2021)
7.2 Europe Functional Dyspepsia Drug Sales by Type
7.3 Europe Functional Dyspepsia Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Functional Dyspepsia Drug by Country
8.1.1 Middle East & Africa Functional Dyspepsia Drug Sales by Country (2016-2021)
8.1.2 Middle East & Africa Functional Dyspepsia Drug Revenue by Country (2016-2021)
8.2 Middle East & Africa Functional Dyspepsia Drug Sales by Type
8.3 Middle East & Africa Functional Dyspepsia Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Functional Dyspepsia Drug Distributors
10.3 Functional Dyspepsia Drug Customer

11 Global Functional Dyspepsia Drug Market Forecast
11.1 Global Functional Dyspepsia Drug Forecast by Region
11.1.1 Global Functional Dyspepsia Drug Forecast by Regions (2021-2026)
11.2.2 Global Functional Dyspepsia Drug Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Functional Dyspepsia Drug Forecast by Type
11.7 Global Functional Dyspepsia Drug Forecast by Application

12 Key Players Analysis
12.1 Bayer
12.1.1 Bayer Company Information
12.1.2 Bayer Functional Dyspepsia Drug Product Offered
12.1.3 Bayer Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Bayer Main Business Overview
12.1.5 Bayer Latest Developments
12.2 Sumitomo
12.2.1 Sumitomo Company Information
12.2.2 Sumitomo Functional Dyspepsia Drug Product Offered
12.2.3 Sumitomo Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Sumitomo Main Business Overview
12.2.5 Sumitomo Latest Developments
12.3 Cadila Pharmaceuticals
12.3.1 Cadila Pharmaceuticals Company Information
12.3.2 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Offered
12.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Cadila Pharmaceuticals Main Business Overview
12.3.5 Cadila Pharmaceuticals Latest Developments
12.4 Teva
12.4.1 Teva Company Information
12.4.2 Teva Functional Dyspepsia Drug Product Offered
12.4.3 Teva Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Teva Main Business Overview
12.4.5 Teva Latest Developments
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Information
12.5.2 Johnson & Johnson Functional Dyspepsia Drug Product Offered
12.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Johnson & Johnson Main Business Overview
12.5.5 Johnson & Johnson Latest Developments
12.6 Pfizer
12.6.1 Pfizer Company Information
12.6.2 Pfizer Functional Dyspepsia Drug Product Offered
12.6.3 Pfizer Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Pfizer Main Business Overview
12.6.5 Pfizer Latest Developments
12.7 Sanofi
12.7.1 Sanofi Company Information
12.7.2 Sanofi Functional Dyspepsia Drug Product Offered
12.7.3 Sanofi Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Sanofi Main Business Overview
12.7.5 Sanofi Latest Developments
12.8 AstraZeneca
12.8.1 AstraZeneca Company Information
12.8.2 AstraZeneca Functional Dyspepsia Drug Product Offered
12.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 AstraZeneca Main Business Overview
12.8.5 AstraZeneca Latest Developments
12.9 Jiangsu Aosaikang Pharma
12.9.1 Jiangsu Aosaikang Pharma Company Information
12.9.2 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Offered
12.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Jiangsu Aosaikang Pharma Main Business Overview
12.9.5 Jiangsu Aosaikang Pharma Latest Developments
12.10 Eisai
12.10.1 Eisai Company Information
12.10.2 Eisai Functional Dyspepsia Drug Product Offered
12.10.3 Eisai Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Eisai Main Business Overview
12.10.5 Eisai Latest Developments
12.11 Kyowa Kirin Pharmaceuticals
12.11.1 Kyowa Kirin Pharmaceuticals Company Information
12.11.2 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Offered
12.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Kyowa Kirin Pharmaceuticals Main Business Overview
12.11.5 Kyowa Kirin Pharmaceuticals Latest Developments
12.12 Hanmi Pharm
12.12.1 Hanmi Pharm Company Information
12.12.2 Hanmi Pharm Functional Dyspepsia Drug Product Offered
12.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Hanmi Pharm Main Business Overview
12.12.5 Hanmi Pharm Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Functional Dyspepsia Drug Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Prokinetic Drugs
Table 3. Major Players of Gastric Antisecretory Drugs
Table 4. Major Players of Others
Table 5. Global Functional Dyspepsia Drug Sales by Type (2016-2021) & (M Units)
Table 6. Global Functional Dyspepsia Drug Sales Market Share by Type (2016-2021)
Table 7. Global Functional Dyspepsia Drug Revenue by Type (2016-2021) & ($ million)
Table 8. Global Functional Dyspepsia Drug Revenue Market Share by Type (2016-2021)
Table 9. Global Functional Dyspepsia Drug Sale Price by Type (2016-2021)
Table 10. Global Functional Dyspepsia Drug Sales by Application (2016-2021) & (M Units)
Table 11. Global Functional Dyspepsia Drug Sales Market Share by Application (2016-2021)
Table 12. Global Functional Dyspepsia Drug Value by Application (2016-2021)
Table 13. Global Functional Dyspepsia Drug Revenue Market Share by Application (2016-2021)
Table 14. Global Functional Dyspepsia Drug Sale Price by Application (2016-2021)
Table 15. Global Functional Dyspepsia Drug Sales by Company (2019-2021) & (M Units)
Table 16. Global Functional Dyspepsia Drug Sales Market Share by Company (2019-2021)
Table 17. Global Functional Dyspepsia Drug Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Functional Dyspepsia Drug Revenue Market Share by Company (2019-2021)
Table 19. Global Functional Dyspepsia Drug Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Functional Dyspepsia Drug Producing Area Distribution and Sales Area
Table 21. Players Functional Dyspepsia Drug Products Offered
Table 22. Functional Dyspepsia Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Functional Dyspepsia Drug Sales by Region (2016-2021) (M Units)
Table 26. Global Functional Dyspepsia Drug Sales Market Share by Region (2016-2021)
Table 27. Global Functional Dyspepsia Drug Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Functional Dyspepsia Drug Revenue Market Share by Region (2016-2021)
Table 29. Americas Functional Dyspepsia Drug Sales by Country (2016-2021) & (M Units)
Table 30. Americas Functional Dyspepsia Drug Sales Market Share by Country (2016-2021)
Table 31. Americas Functional Dyspepsia Drug Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Functional Dyspepsia Drug Revenue Market Share by Country (2016-2021)
Table 33. Americas Functional Dyspepsia Drug Sales by Type (2016-2021) & (M Units)
Table 34. Americas Functional Dyspepsia Drug Sales Market Share by Type (2016-2021)
Table 35. Americas Functional Dyspepsia Drug Sales by Application (2016-2021) & (M Units)
Table 36. Americas Functional Dyspepsia Drug Sales Market Share by Application (2016-2021)
Table 37. APAC Functional Dyspepsia Drug Sales by Region (2016-2021) & (M Units)
Table 38. APAC Functional Dyspepsia Drug Sales Market Share by Region (2016-2021)
Table 39. APAC Functional Dyspepsia Drug Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Functional Dyspepsia Drug Revenue Market Share by Region (2016-2021)
Table 41. APAC Functional Dyspepsia Drug Sales by Type (2016-2021) & (M Units)
Table 42. APAC Functional Dyspepsia Drug Sales Market Share by Type (2016-2021)
Table 43. APAC Functional Dyspepsia Drug Sales by Application (2016-2021) & (M Units)
Table 44. APAC Functional Dyspepsia Drug Sales Market Share by Application (2016-2021)
Table 45. Europe Functional Dyspepsia Drug Sales by Country (2016-2021) & (M Units)
Table 46. Europe Functional Dyspepsia Drug Sales Market Share by Country (2016-2021)
Table 47. Europe Functional Dyspepsia Drug Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Functional Dyspepsia Drug Revenue Market Share by Country (2016-2021)
Table 49. Europe Functional Dyspepsia Drug Sales by Type (2016-2021) & (M Units)
Table 50. Europe Functional Dyspepsia Drug Sales Market Share by Type (2016-2021)
Table 51. Europe Functional Dyspepsia Drug Sales by Application (2016-2021) & (M Units)
Table 52. Europe Functional Dyspepsia Drug Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Functional Dyspepsia Drug Sales by Country (2016-2021) & (M Units)
Table 54. Middle East & Africa Functional Dyspepsia Drug Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Functional Dyspepsia Drug Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Functional Dyspepsia Drug Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Functional Dyspepsia Drug Sales by Type (2016-2021) & (M Units)
Table 58. Middle East & Africa Functional Dyspepsia Drug Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Functional Dyspepsia Drug Sales by Application (2016-2021) & (M Units)
Table 60. Middle East & Africa Functional Dyspepsia Drug Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Functional Dyspepsia Drug
Table 62. Key Application and Potential Industries of Functional Dyspepsia Drug
Table 63. Key Challenges of Functional Dyspepsia Drug
Table 64. Key Trends of Functional Dyspepsia Drug
Table 65. Functional Dyspepsia Drug Distributors List
Table 66. Functional Dyspepsia Drug Customer List
Table 67. Global Functional Dyspepsia Drug Sales Forecast by Region (2021-2026) & (M Units)
Table 68. Global Functional Dyspepsia Drug Consumption Market Forecast by Region
Table 69. Global Functional Dyspepsia Drug Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Functional Dyspepsia Drug Sales Forecast by Country (2021-2026) & (M Units)
Table 72. Americas Functional Dyspepsia Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Functional Dyspepsia Drug Sales Forecast by Region (2021-2026) & (M Units)
Table 74. APAC Functional Dyspepsia Drug Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Functional Dyspepsia Drug Sales Forecast by Country (2021-2026) & (M Units)
Table 76. Europe Functional Dyspepsia Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Functional Dyspepsia Drug Sales Forecast by Country (2021-2026) & (M Units)
Table 78. Middle East & Africa Functional Dyspepsia Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Functional Dyspepsia Drug Sales Forecast by Type (2021-2026) & (M Units)
Table 80. Global Functional Dyspepsia Drug Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Functional Dyspepsia Drug Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Functional Dyspepsia Drug Sales Forecast by Application (2021-2026) & (M Units)
Table 84. Global Functional Dyspepsia Drug Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Functional Dyspepsia Drug Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Application (2021-2026)
Table 87. Bayer Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Bayer Functional Dyspepsia Drug Product Offered
Table 89. Bayer Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. Bayer Main Business
Table 91. Bayer Latest Developments
Table 92. Sumitomo Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Sumitomo Functional Dyspepsia Drug Product Offered
Table 94. Sumitomo Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. Sumitomo Main Business
Table 96. Sumitomo Latest Developments
Table 97. Cadila Pharmaceuticals Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Cadila Pharmaceuticals Functional Dyspepsia Drug Product Offered
Table 99. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. Cadila Pharmaceuticals Main Business
Table 101. Cadila Pharmaceuticals Latest Developments
Table 102. Teva Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Functional Dyspepsia Drug Product Offered
Table 104. Teva Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Teva Main Business
Table 106. Teva Latest Developments
Table 107. Johnson & Johnson Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Johnson & Johnson Functional Dyspepsia Drug Product Offered
Table 109. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Johnson & Johnson Main Business
Table 111. Johnson & Johnson Latest Developments
Table 112. Pfizer Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Functional Dyspepsia Drug Product Offered
Table 114. Pfizer Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. Pfizer Main Business
Table 116. Pfizer Latest Developments
Table 117. Sanofi Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Sanofi Functional Dyspepsia Drug Product Offered
Table 119. Sanofi Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 120. Sanofi Main Business
Table 121. Sanofi Latest Developments
Table 122. AstraZeneca Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. AstraZeneca Functional Dyspepsia Drug Product Offered
Table 124. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 125. AstraZeneca Main Business
Table 126. AstraZeneca Latest Developments
Table 127. Jiangsu Aosaikang Pharma Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Offered
Table 129. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 130. Jiangsu Aosaikang Pharma Main Business
Table 131. Jiangsu Aosaikang Pharma Latest Developments
Table 132. Eisai Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Eisai Functional Dyspepsia Drug Product Offered
Table 134. Eisai Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 135. Eisai Main Business
Table 136. Eisai Latest Developments
Table 137. Kyowa Kirin Pharmaceuticals Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Offered
Table 139. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 140. Kyowa Kirin Pharmaceuticals Main Business
Table 141. Kyowa Kirin Pharmaceuticals Latest Developments
Table 142. Hanmi Pharm Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. Hanmi Pharm Functional Dyspepsia Drug Product Offered
Table 144. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 145. Hanmi Pharm Main Business
Table 146. Hanmi Pharm Latest Developments

List of Figures
Figure 1. Picture of Functional Dyspepsia Drug
Figure 2. Functional Dyspepsia Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Functional Dyspepsia Drug Sales Growth Rate 2016-2026 (M Units)
Figure 7. Global Functional Dyspepsia Drug Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Functional Dyspepsia Drug Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Prokinetic Drugs
Figure 10. Product Picture of Gastric Antisecretory Drugs
Figure 11. Product Picture of Others
Figure 12. Global Functional Dyspepsia Drug Sales Market Share by Type in 2020
Figure 13. Global Functional Dyspepsia Drug Revenue Market Share by Type (2016-2021)
Figure 14. Functional Dyspepsia Drug Consumed in Hospitals
Figure 15. Global Functional Dyspepsia Drug Market: Hospitals (2016-2021) & (M Units)
Figure 16. Functional Dyspepsia Drug Consumed in Drugstores
Figure 17. Global Functional Dyspepsia Drug Market: Drugstores (2016-2021) & (M Units)
Figure 18. Global Functional Dyspepsia Drug Sales Market Share by Application (2016-2021)
Figure 19. Global Functional Dyspepsia Drug Revenue Market Share by Application in 2020
Figure 20. Functional Dyspepsia Drug Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Functional Dyspepsia Drug Revenue Market Share by Company in 2020
Figure 22. Global Functional Dyspepsia Drug Sales Market Share by Regions (2016-2021)
Figure 23. Global Functional Dyspepsia Drug Revenue Market Share by Region in 2020
Figure 24. Americas Functional Dyspepsia Drug Sales 2016-2021 (M Units)
Figure 25. Americas Functional Dyspepsia Drug Revenue 2016-2021 ($ Millions)
Figure 26. APAC Functional Dyspepsia Drug Sales 2016-2021 (M Units)
Figure 27. APAC Functional Dyspepsia Drug Revenue 2016-2021 ($ Millions)
Figure 28. Europe Functional Dyspepsia Drug Sales 2016-2021 (M Units)
Figure 29. Europe Functional Dyspepsia Drug Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Functional Dyspepsia Drug Sales 2016-2021 (M Units)
Figure 31. Middle East & Africa Functional Dyspepsia Drug Revenue 2016-2021 ($ Millions)
Figure 32. Americas Functional Dyspepsia Drug Sales Market Share by Country in 2020
Figure 33. Americas Functional Dyspepsia Drug Revenue Market Share by Country in 2020
Figure 34. Americas Functional Dyspepsia Drug Sales Market Share by Type in 2020
Figure 35. Americas Functional Dyspepsia Drug Sales Market Share by Application in 2020
Figure 36. United States Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Functional Dyspepsia Drug Sales Market Share by Region in 2020
Figure 41. APAC Functional Dyspepsia Drug Revenue Market Share by Regions in 2020
Figure 42. APAC Functional Dyspepsia Drug Sales Market Share by Type in 2020
Figure 43. APAC Functional Dyspepsia Drug Sales Market Share by Application in 2020
Figure 44. China Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Functional Dyspepsia Drug Sales Market Share by Country in 2020
Figure 51. Europe Functional Dyspepsia Drug Revenue Market Share by Country in 2020
Figure 52. Europe Functional Dyspepsia Drug Sales Market Share by Type in 2020
Figure 53. Europe Functional Dyspepsia Drug Sales Market Share by Application in 2020
Figure 54. Germany Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Functional Dyspepsia Drug Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Functional Dyspepsia Drug Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Functional Dyspepsia Drug Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Functional Dyspepsia Drug Sales Market Share by Application in 2020
Figure 63. Egypt Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Functional Dyspepsia Drug Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles

Report Title: Global Functional Dyspepsia Drug Market Growth 2021-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW